Physician profile
Dean Trevlyn
NPI 1609819689
$5,970.95
in general payments reported to CMS, 2019-2025
21 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $237 · 2021: $958 · 2023: $368 · 2024: $1,970 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,395 · Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,394.63 |
| Food and Beverage | $1,207.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,743.76 | 2021-2025 | Comprehensive Shoulder System, Comprehensive, Gel-One Cross-Linked Hyaluronate |
| Arthrex, INC. | $1,130.50 | 2019 | |
| Liberty Surgical INC. | $705.68 | 2019 | |
| Depuy Synthes Sales INC. | $205.68 | 2019-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $187.27 | 2019-2024 | Triathlon |
| Heraeus Medical, LLC. | $169.80 | 2019-2025 | Palacos |
| Bioventus LLC | $145.62 | 2020-2023 | Durolane |
| Smith+Nephew, INC. | $127.44 | 2019-2025 | Polarstem |
| Fidia Pharma USA INC. | $117.56 | 2019-2025 | Hymovis |
| Pacira Therapeutics, INC. | $108.09 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $76.75 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $53.52 | 2025 | Euflexxa |
| Eclipse Technology Solutions INC. | $35.43 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $32.40 | 2025 | |
| Orthofix Medical, INC. | $22.33 | 2024-2025 | Cervical-Stim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $21.05 | 2019 | |
| Prescient Lab Services, LLC | $20.01 | 2025 | Avertd Intellipac Reagent Module, Avertd Biofilmchip Microarray Magazine, Avertd Amplification Mix |
| Wright Medical Technology, INC. | $20.01 | 2020 | |
| Baxter Healthcare | $19.91 | 2023 | Tisseel |
| Davol INC. | $14.84 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.30 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Trevlyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.